1. Home
  2. ACRV vs TOUR Comparison

ACRV vs TOUR Comparison

Compare ACRV & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$2.46

Market Cap

74.5M

Sector

Health Care

ML Signal

HOLD

Logo Tuniu Corporation

TOUR

Tuniu Corporation

HOLD

Current Price

$0.71

Market Cap

87.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRV
TOUR
Founded
2018
2006
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
74.5M
87.0M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
ACRV
TOUR
Price
$2.46
$0.71
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
431.3K
399.1K
Earning Date
11-13-2025
12-05-2025
Dividend Yield
N/A
5.07%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
N/A
$78,261,883.00
Revenue This Year
N/A
$12.27
Revenue Next Year
$805.20
$10.18
P/E Ratio
N/A
$108.67
Revenue Growth
N/A
9.07
52 Week Low
$1.05
$0.62
52 Week High
$8.00
$1.17

Technical Indicators

Market Signals
Indicator
ACRV
TOUR
Relative Strength Index (RSI) 55.77 48.18
Support Level $2.12 $0.62
Resistance Level $2.59 $0.76
Average True Range (ATR) 0.19 0.05
MACD -0.00 0.00
Stochastic Oscillator 59.17 64.36

Price Performance

Historical Comparison
ACRV
TOUR

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

Share on Social Networks: